BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
-0.49%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.95B
AUM Growth
+$2.95B
Cap. Flow
+$66.5M
Cap. Flow %
2.25%
Top 10 Hldgs %
48.26%
Holding
91
New
14
Increased
7
Reduced
3
Closed
6

Top Buys

1
CGEM icon
Cullinan Oncology
CGEM
$44.8M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$40.2M
3
CNTB
Connect Biopharma
CNTB
$38.5M
4
NUVB icon
Nuvation Bio
NUVB
$37M
5
ACHL
Achilles Therapeutics plc American Depositary Shares
ACHL
$25.4M

Top Sells

1
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$122M
2
PAND
Pandion Therapeutics Inc. Common Stock
PAND
$31.3M
3
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
$25.9M
4
LABD icon
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$21.7M
5
CLDX icon
Celldex Therapeutics
CLDX
$17.5M

Sector Composition

1 Healthcare 96.52%
2 Financials 0.94%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$343M 11.62% 2,000,000 +234,440 +13% +$40.2M
ONC
2
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$266M 9.02% 764,188 -350,000 -31% -$122M
RVMD icon
3
Revolution Medicines
RVMD
$7.1B
$160M 5.42% 3,484,264 +175,000 +5% +$8.03M
SWTX
4
DELISTED
SpringWorks Therapeutics
SWTX
$153M 5.18% 2,075,905 – –
ITOS icon
5
iTeos Therapeutics
ITOS
$149M 5.04% 4,345,016 – –
SAGE
6
DELISTED
Sage Therapeutics
SAGE
$81.9M 2.78% 1,094,000 – –
PMVP icon
7
PMV Pharmaceuticals
PMVP
$74.2M
$74.6M 2.53% 2,268,236 – –
SPRY icon
8
ARS Pharmaceuticals
SPRY
$1.15B
$73.1M 2.48% 1,675,377 – –
RCKT icon
9
Rocket Pharmaceuticals
RCKT
$354M
$65M 2.21% 1,466,051 – –
RCUS icon
10
Arcus Biosciences
RCUS
$1.13B
$58.5M 1.99% 2,084,883 – –
SGEN
11
DELISTED
Seagen Inc. Common Stock
SGEN
$55.5M 1.88% 400,000 – –
IDYA icon
12
IDEAYA Biosciences
IDYA
$2.15B
$51.8M 1.76% 2,202,812 – –
SNDX icon
13
Syndax Pharmaceuticals
SNDX
$1.41B
$51.2M 1.73% 2,287,782 – –
BDTX icon
14
Black Diamond Therapeutics
BDTX
$157M
$48.9M 1.66% 2,014,858 – –
CYTK icon
15
Cytokinetics
CYTK
$4.23B
$48.8M 1.66% 2,100,000 – –
ARGX icon
16
argenx
ARGX
$43.6B
$47.1M 1.6% 170,926 – –
NUVB icon
17
Nuvation Bio
NUVB
$1.02B
$45.4M 1.54% 4,341,009 +3,541,009 +443% +$37M
CGEM icon
18
Cullinan Oncology
CGEM
$445M
$44.8M 1.52% +1,074,082 New +$44.8M
RLAY icon
19
Relay Therapeutics
RLAY
$619M
$44.7M 1.52% 1,294,132 – –
DBVT
20
DBV Technologies
DBVT
$264M
$40.2M 1.36% 7,534,598 – –
MRUS icon
21
Merus
MRUS
$4.98B
$39.7M 1.35% 1,900,000 +472,151 +33% +$9.86M
CNTB
22
Connect Biopharma
CNTB
$115M
$38.5M 1.31% +2,081,323 New +$38.5M
NRIX icon
23
Nurix Therapeutics
NRIX
$714M
$38.1M 1.29% 1,224,892 – –
AMRN
24
Amarin Corp
AMRN
$311M
$37.3M 1.26% 6,000,000 – –
MRNS
25
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$37.2M 1.26% 2,400,000 – –
1
2 3 4